Community-based Tuberculosis Tracing and Preventive Therapy
- Conditions
- Tuberculosis
- Interventions
- Other: Screening and initiating preventive therapy in communities
- Registration Number
- NCT03832023
- Lead Sponsor
- Elizabeth Glaser Pediatric AIDS Foundation
- Brief Summary
The many gaps observed in the cascade of care of tuberculosis (TB) child contacts occur mostly in the screening, preventive therapy (PT) initiation and PT completion steps and the main drivers of these gaps are considered to be the health system infrastructure, limited worker resources and parents' reluctance to bring their children to the facility for screening. There would be great advantages of using a symptom-based screening at community level where only the symptomatic contacts are referred to hospital for further evaluation and asymptomatic contacts are started on PT in the community. Household or community-based screening is likely to improve the uptake and acceptability of child contact screening and management as well as adherence to PT and to reduce cost and workload at facility level.
This study proposes to compare the cascade of care between two models for TB screening and management of household TB child contacts in two high TB burden and limited resource countries, Cameroon and Uganda. In the facility-based model, children will be screened at facility (Cameroon) or household level (Uganda) and preventive therapy initiation, refills of PT therapy and follow-up will be done at facility level. In the intervention group (community-based model), child contacts will be screened in the household by a community health worker (CHW). Those with symptoms suggestive of TB will be referred to the facility for TB investigations. Asymptomatic child contacts from high risk groups (under-5 years or HIV infected 5-14) will be initiated on PT (3 months isoniazid-rifampicin) in the household. Refills of PT therapy will also be done in the communities by the CHW. In both models, symptomatic children requiring further investigations for TB diagnosis will be referred to a health facility.
- Detailed Description
The primary study objective is to compare the proportion of household child TB contacts eligible for PT (under-5 years and HIV-infected children 5-14 years without active TB) who initiate and complete PT using facility-based and decentralized community-based models of care for contact screening and management.
Secondary objectives are:
1. To compare the facility and community-based models in terms of:
* The full cascade of care for the initiation and completion of PT in child TB contacts \< 5 years or HIV+ children 5-14 years .
* Cascade of care for the detection and treatment of TB in child contacts (all ages):
* PT tolerability and adherence among eligible child contacts initiated on PT.
* Treatment uptake and outcomes for child contacts diagnosed with TB .
* Child contact outcomes at 6 months after enrollment for all child contacts.
* Acceptability by the parents/guardians, health personnel and community of the different models of care.
* Cost and cost-effectiveness of the different models.
* Fidelity of the implementation of the model activities as compared to the protocol.
2. To assess the number of adult contact cases diagnosed with TB through the community-based screening.
3. To compare between the pre- (baseline assessment) and post-intervention (by model of care) data related to:
* Children diagnosed with TB and registered at facility level and their treatment outcome.
* Adults diagnosed with TB and registered at facility level and their treatment outcome.
* PT initiation and outcomes.
This study will be implemented under the frame of the Catalyzing Pediatric TB Innovation (CaP TB) Project, funded by Unitaid and implemented by the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF). The goal of CaP TB is to improve the pediatric TB morbidity and mortality by catalyzing the wide uptake of the new first-line fixed dose combination drugs for children and optimizing the use of these drugs through improved case detection and innovative models of care. In both models of care, contacts with TB suggestive symptoms will be investigated for TB at the cluster facility that is supported by EGPAF within the CaP TB project. In Cameroon the CaP TB project will be implemented in the Central and Littoral regions and in Uganda in the South-West region.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1400
-
Inclusion of the index cases
- Age > 15 years
- Newly bacteriologically confirmed TB case (less than a month since diagnosis)
- Reports child contact(s)
- Written informed consent signed by the index case and by parents/guardians for minors or incapacitated people
-
Inclusion of contacts
- Household contact
- Age
- Facility-based model in Cameroon: < 5 years or HIV infected 5-14 years and all self-referred adults or children*.
- Facility-based model in Uganda and community-based model on both countries: all ages
- Written informed consent signed by adult contacts and by parents/guardians for minors or incapacitated people
- Written assent for children > 7 years in Cameroon and ≥8 years in Uganda
Under the facility-based model in Cameroon, although there is no systematic request to screen adults or HIV-negative child contacts 5-14 years old, first inclusions showed that some of them came by themselves for TB screening. This justifies their inclusion in the study in order to ensure the completeness of data for all contacts screened under the facility-based model.
- Exclusion of index cases
- Index cases who do not have child household contacts living in the catchment area of one of the study clusters
- Index cases diagnosed with rifampicin resistance, multidrug-resistant (MDR) or extensively drug-resistant (XDR) TB *Index cases from a household screened within the CONTACT study and that does not declare child contacts from another household.*
- Index cases that are prisoners
TB confirmed adult contacts cases living in the same household as an index case already enrolled in the study will not be included as new index cases unless they declare additional contacts from another household
- Exclusion of the contacts
- If the contact is already on PT or on TB treatment
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Community-based model Screening and initiating preventive therapy in communities Screening and initiating preventive therapy in communities
- Primary Outcome Measures
Name Time Method Completion of preventive therapy 6 months Proportion of child TB contacts \<5 years of age and HIV-infected children of 5-14 years of age who initiate and complete the PT of all child contacts \<5 years of age and HIV-infected children of 5-14 years of age declared by the index case
- Secondary Outcome Measures
Name Time Method Proportion of children with serious adverse events 6 months Number of children with serious adverse events among children started on PT
Reasons of refusal of household visit 2 years Description of screening failures
Proportion of adult contacts screened 1 month Number of adult contacts screened among household identified adult contacts
Proportion of children diagnosed with TB 6 months Number of children diagnosed with TB after initiation of PT or children not initiated on PT and not diagnosed with TB at baseline
Proportion of children started on TB treatment 1 month Number of children with TB diagnosis who are started on TB treatment
Proportion of adults presumptive TB cases 1 month Number of adults with symptoms suggestive of TB among those screened for TB
Proportion of children with presumptive TB 1 month Number of children with symptoms suggestive of TB among screened children (\< 15 years)
Proportion of children screened 6 months Number of children screened among child contacts \<5 years or HIV-infected 5-14 years declared by the index case
Proportion of children eligible for PT 6 months Number of children eligible for PT among screened children
Proportion of children investigated for TB 1 month Number of children with presumptive TB investigated for TB
Proportion of adults diagnosed with TB 1 month Number of adults presumptive TB cases diagnosed with TB
Proportion of children started on PT 6 months Number of children started on PT among those eligible for PT
Proportion of children who did not complete PT 6 months Number of children who did not complete PT among those started on PT
Proportion of children with adverse event of interest 6 months Number of children with adverse event of interest (peripheral neuropathy, clinical hepatotoxicity) among children on PT
Treatment adherence 6 months Ratio of PT dose taken by the child over the total number of doses prescribed
Treatment outcomes of children started on TB treatment 6 months * Cured
* Treatment completed
* Failure
* Death
* Lost to follow up
* Transferred outTB treatment outcome of registered TB patients during pre-intervention period 2 years * Cured
* Treatment completed
* Failure
* Death
* Lost to follow up
* Transferred outCompletion rate of children started on PT intervention during pre-intervention period 2 years Number of children who completed PT among those started on PT from the facility PT register one year before
Number of household visits by CHW 2 years Number of visits by the CHW to the household for contact screening per household
TB case detection during pre-intervention period 2 years Number of patients registered in the facility TB register one year before intervention
Proportion of children among all registered TB cases during pre-intervention period 2 years Number of children among all patients diagnosed with TB and registered in the facility TB register one year before intervention
Number of children started on PT during pre-intervention period 2 years Number of children started on PT from the facility PT register one year before intervention
Proportion of parents/guardians who accept household visit 2 years Acceptability of household visit for contact screening
Preference for household visit versus facility visit 2 years This outcome measures whether the parent/guardian prefers bringing child to the facility rather than having someone coming to his household
Critical events experienced by CHW during household visit 2 years Description of critical events during house visit and how these where dealt with
Transport cost for household visit by CHW 2 years Cost of transportation for the CHW to go from the health facility to a household
Transport cost for parents/guardian for facility-based screening 2 years Cost supported by families to bring child contact to the facility for screening
Time spent to perform household contact screening visit 2 years It includes the time to reach the household, the time spent in the household and the time to go back to the facility for CHW
Proportion of delivered activities compared to the intended activities of the model 2 years This outcome will assess fidelity to study procedures
Trial Locations
- Locations (25)
Bubaare HC III
🇺🇬Mbarara, Uganda
Bwizibwera HC IV
🇺🇬Mbarara, Uganda
Ruhoko HC IV
🇺🇬Ibanda, Uganda
Kabwohe Clinical Research Center HC II
🇺🇬Kabwohe, Uganda
Kakoba HC III
🇺🇬Mbarara, Uganda
Mbarara Municipal Council HC IV
🇺🇬Mbarara, Uganda
Itojo Hospital
🇺🇬Ntungamo, Uganda
Ishongororo HC IV
🇺🇬Ibanda, Uganda
Kabwohe HC IV
🇺🇬Kabwohe, Uganda
Kitagata Hospital
🇺🇬Kitagata, Uganda
Kitwe HC IV
🇺🇬Ntungamo, Uganda
Ntungamo Ngoma HC III
🇺🇬Ntungamo, Uganda
Bwongyera HC III
🇺🇬Ntungamo, Uganda
Rubaare HC IV
🇺🇬Ntungamo, Uganda
Rwashamaire HC IV
🇺🇬Ntungamo, Uganda
Hôpital de district Bonassama
🇨🇲Bonabéri, Cameroon
Centre Médical d'arrondissement Delangue
🇨🇲Edéa, Cameroon
Hôpital de district St Jean de Malte
🇨🇲Penja, Cameroon
Hôpital de district Yoko
🇨🇲Yoko, Cameroon
Hôpital de district Mfou
🇨🇲Mfou, Cameroon
Hôpital de district Olembe
🇨🇲Olembe, Cameroon
Hôpital de district Okola
🇨🇲Okola, Cameroon
Hôpital régional Nkongsamba
🇨🇲Nkongsamba, Cameroon
Hôpital de district Mbalmayo
🇨🇲Mbalmayo, Cameroon
Hôpital de district Log-Baba
🇨🇲Douala, Cameroon